Thalidomide-NH-CH2-COOH trifluoroacetate salt

Background Introduction

Thalidomide-NH-CH2-COOH trifluoroacetate salt is a chemically synthetic E3 ligase ligand-linker conjugate. It is derived from thalidomide, a well-known cereblon (CRBN) E3 ubiquitin ligase modulator, and is specifically designed for constructing PROTAC (Proteolysis Targeting Chimera) molecules. The addition of a carboxylic acid group (-COOH) via an alkyl linker makes this molecule amenable for further conjugation, enabling researchers to connect various target protein binders with an E3 ligase ligand for targeted protein degradation.

Mechanism

Thalidomide-NH-CH2-COOH trifluoroacetate salt works as a vital building block in PROTAC synthesis. The thalidomide scaffold binds selectively to cereblon (CRBN), a substrate receptor of the CUL4 E3 ubiquitin ligase complex. The linker, terminated by a carboxyl (-COOH) group, offers a conjugation site for attaching ligands that recognize other proteins of interest. When incorporated into a PROTAC molecule, this conjugate brings the target protein into proximity with the E3 ligase, leading to ubiquitination and subsequent proteasomal degradation of the target protein. This mechanism enables selective and catalytic protein knockdown with high specificity.

Applications

Thalidomide-NH-CH2-COOH trifluoroacetate salt is widely utilized in medicinal chemistry, chemical biology, and drug discovery research. Its primary application is as a functionalized E3 ligase ligand for PROTAC development, facilitating the targeted degradation of disease-related proteins, including those considered 'undruggable' by conventional inhibitors. This product is suitable for academic and pharmaceutical researchers aiming to explore novel therapeutic modalities, conduct target validation studies, or develop next-generation drugs leveraging protein degradation pathways. Additionally, it can be used to create bifunctional molecules for targeted protein modulation in mechanistic and cellular studies.

The E3 Ligase Ligand-Linker Conjugate, Thalidomide-NH-CH2-COOH trifluoroacetate salt, plays a crucial role in PROTACs by facilitating targeted protein degradation through a well-designed combination of linker and ligand components. This molecule is essential for researchers seeking to harness the power of targeted protein degradation. The following provides a detailed description of this molecule.

Linker: The linker in this molecule is a short, flexible alkyl chain that provides optimal spatial orientation for the conjugation of the ligand to the target protein. Its non-cleavable nature ensures stability, maintaining the integrity of the PROTAC during cellular processes.

Ligand: The ligand component is based on thalidomide, a well-established E3 ligase-binding moiety. Its structural characteristics include a glutarimide ring, which is crucial for high-affinity binding to the cereblon E3 ligase complex, facilitating effective protein degradation.

Reactive Site: The reactive site features a carboxylic acid group, which is ideal for coupling with amine-containing target protein ligands through amide bond formation. This reaction type is favored due to its stability and efficiency in forming a robust linkage.

Recommended Target Protein Ligand: The recommended warhead for this molecule is an amine-functionalized ligand, which allows for a stable amide bond formation with the carboxylic acid group. This warhead is advantageous due to its compatibility with a wide range of target proteins, enabling versatile applications in studying protein function and degradation pathways in cellular environments.